PureTech Health (PRTC) Competitors $18.23 -1.44 (-7.34%) Closing price 07/22/2025 03:58 PM EasternExtended Trading$18.73 +0.50 (+2.74%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRTC vs. IMCR, TARS, APGE, OCUL, VCEL, SPRY, ARQT, ADPT, SDGR, and JANXShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Immunocore (IMCR), Tarsus Pharmaceuticals (TARS), Apogee Therapeutics (APGE), Ocular Therapeutix (OCUL), Vericel (VCEL), ARS Pharmaceuticals (SPRY), Arcutis Biotherapeutics (ARQT), Adaptive Biotechnologies (ADPT), Schrodinger (SDGR), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Its Competitors Immunocore Tarsus Pharmaceuticals Apogee Therapeutics Ocular Therapeutix Vericel ARS Pharmaceuticals Arcutis Biotherapeutics Adaptive Biotechnologies Schrodinger Janux Therapeutics PureTech Health (NASDAQ:PRTC) and Immunocore (NASDAQ:IMCR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends. Which has more risk and volatility, PRTC or IMCR? PureTech Health has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Immunocore has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500. Is PRTC or IMCR more profitable? PureTech Health has a net margin of 0.00% compared to Immunocore's net margin of -6.48%. PureTech Health's return on equity of 0.00% beat Immunocore's return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A Immunocore -6.48%-5.86%-2.09% Which has higher valuation and earnings, PRTC or IMCR? PureTech Health has higher earnings, but lower revenue than Immunocore. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$4.83M90.64$27.78MN/AN/AImmunocore$310.20M6.02-$51.09M-$0.43-86.40 Do analysts recommend PRTC or IMCR? PureTech Health presently has a consensus price target of $45.00, indicating a potential upside of 146.90%. Immunocore has a consensus price target of $58.89, indicating a potential upside of 58.52%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts clearly believe PureTech Health is more favorable than Immunocore.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Immunocore 1 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.55 Does the media favor PRTC or IMCR? In the previous week, PureTech Health had 2 more articles in the media than Immunocore. MarketBeat recorded 2 mentions for PureTech Health and 0 mentions for Immunocore. PureTech Health's average media sentiment score of 0.00 equaled Immunocore'saverage media sentiment score. Company Overall Sentiment PureTech Health Neutral Immunocore Neutral Do institutionals and insiders hold more shares of PRTC or IMCR? 0.0% of PureTech Health shares are held by institutional investors. Comparatively, 84.5% of Immunocore shares are held by institutional investors. 5.3% of PureTech Health shares are held by company insiders. Comparatively, 10.4% of Immunocore shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryPureTech Health beats Immunocore on 10 of the 14 factors compared between the two stocks. Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$472.52M$2.93B$5.49B$9.45BDividend YieldN/A2.49%4.01%4.03%P/E RatioN/A20.5328.4719.90Price / Sales90.64266.81410.1985.18Price / Cash8.2541.6635.9658.29Price / Book1.077.808.365.67Net Income$27.78M-$55.10M$3.24B$258.18M7 Day Performance-1.93%4.62%3.13%2.81%1 Month Performance3.79%17.99%10.98%13.53%1 Year Performance-19.00%2.21%34.54%17.68% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health1.9988 of 5 stars$18.23-7.3%$45.00+146.9%-16.8%$472.52M$4.83M0.00100Upcoming EarningsGap DownIMCRImmunocore1.0653 of 5 stars$36.93+1.7%$58.89+59.5%-5.4%$1.82B$310.20M-85.88320TARSTarsus Pharmaceuticals1.487 of 5 stars$42.18-2.5%$66.67+58.1%+56.0%$1.82B$182.95M-15.4550APGEApogee Therapeutics3.3165 of 5 stars$39.11-0.5%$99.00+153.1%-21.1%$1.81BN/A-10.8691OCULOcular Therapeutix3.6592 of 5 stars$11.52+1.7%$17.33+50.5%+46.9%$1.80B$59.65M-10.02230VCELVericel3.8123 of 5 stars$35.46+0.3%$61.14+72.4%-26.4%$1.78B$237.22M1,178.00300News CoverageSPRYARS Pharmaceuticals3.084 of 5 stars$17.85-0.4%$31.00+73.7%+63.6%$1.76B$89.15M-111.5690Positive NewsARQTArcutis Biotherapeutics2.2218 of 5 stars$14.34-2.2%$18.80+31.1%+47.7%$1.75B$196.54M-13.79150Positive NewsADPTAdaptive Biotechnologies3.002 of 5 stars$10.31-0.8%$10.57+2.5%+153.1%$1.58B$178.96M-10.74790SDGRSchrodinger2.0799 of 5 stars$22.82+6.4%$32.75+43.5%-1.9%$1.57B$207.54M-8.68790Positive NewsUpcoming EarningsJANXJanux Therapeutics2.7903 of 5 stars$26.08-1.2%$91.89+252.3%-44.7%$1.56B$10.59M-19.1830News Coverage Related Companies and Tools Related Companies IMCR Alternatives TARS Alternatives APGE Alternatives OCUL Alternatives VCEL Alternatives SPRY Alternatives ARQT Alternatives ADPT Alternatives SDGR Alternatives JANX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRTC) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
